AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial ...
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration ...
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report) and keeping the price target at ...
EST Cathie Wood’s ARK Investment buys 609K shares of Absci (ABSI) todayStay Ahead of the Market:Discover outperforming stocks and invest ...
Absci Corp (ABSI) stock saw a modest uptick, ending the day at $3.22 which represents a slight increase of $0.15 or 4.89% from the prior close of $3.07. The stock opened at $4.09 and touched a low of ...
AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...
Absci (ABSI) was rising after a media report on a $20M investment by the semiconductor company Advanced Micro Devices (AMD) in the AI drug creation company.